Anavex Life Sciences Corp. (AVXL)
1.19
-0.11
(-8.46%)
USD |
NASDAQ |
Oct 30, 16:00
1.19
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Market Cap : 110.31M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 110.31M |
| October 29, 2026 | 120.51M |
| October 28, 2026 | 120.51M |
| October 27, 2026 | 121.43M |
| October 26, 2026 | 118.65M |
| October 23, 2026 | 123.29M |
| October 22, 2026 | 126.07M |
| October 21, 2026 | 126.07M |
| October 20, 2026 | 126.07M |
| October 19, 2026 | 115.87M |
| October 16, 2026 | 121.43M |
| October 15, 2026 | 137.19M |
| October 14, 2026 | 138.12M |
| October 13, 2026 | 137.19M |
| October 12, 2026 | 139.97M |
| October 09, 2026 | 138.12M |
| October 08, 2026 | 142.75M |
| October 07, 2026 | 141.83M |
| October 06, 2026 | 148.31M |
| October 05, 2026 | 152.49M |
| October 02, 2026 | 168.71M |
| October 01, 2026 | 175.20M |
| September 30, 2026 | 187.25M |
| September 29, 2026 | 218.76M |
| September 28, 2026 | 217.84M |
| Date | Value |
|---|---|
| September 25, 2026 | 220.62M |
| September 24, 2026 | 216.91M |
| September 23, 2026 | 217.84M |
| September 22, 2026 | 228.96M |
| September 21, 2026 | 222.47M |
| September 18, 2026 | 224.33M |
| September 17, 2026 | 223.40M |
| September 16, 2026 | 218.76M |
| September 15, 2026 | 226.18M |
| September 14, 2026 | 241.01M |
| September 11, 2026 | 242.87M |
| September 10, 2026 | 246.57M |
| September 09, 2026 | 254.92M |
| September 08, 2026 | 264.19M |
| September 04, 2026 | 265.11M |
| September 03, 2026 | 264.19M |
| September 02, 2026 | 267.89M |
| September 01, 2026 | 266.04M |
| August 31, 2026 | 259.55M |
| August 28, 2026 | 277.16M |
| August 27, 2026 | 290.14M |
| August 26, 2026 | 300.34M |
| August 25, 2026 | 330.00M |
| August 24, 2026 | 288.21M |
| August 21, 2026 | 300.26M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vaxcyte, Inc. | 8.981B |
| Foghorn Therapeutics, Inc. | 122.13M |
| Connect Biopharma Holdings Ltd. | 50.52M |
| Caribou Biosciences, Inc. | 44.86M |
| Arrowhead Pharmaceuticals, Inc. | 8.454B |
Market Cap Related Metrics
| Price to Book Value | 0.981 |
| Price | 1.19 |
| Earnings Yield | -12.74% |